Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD? - Wikidata - awgldk - TriplyDB

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

http://www.wikidata.org/entity/Q33878940

about

COPD and exercise: does it make a difference?Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management Cardiovascular risk, chronic obstructive pulmonary disease and pulmonary rehabilitation: Can we learn from cardiac rehabilitation?Determinants of arterial stiffness in COPD Physical inactivity and arterial stiffness in COPD.Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.Pulmonary Rehabilitation in COPD: A Reappraisal (2008-2012)Impaired training-induced adaptation of blood pressure in COPD patients: implication of the muscle capillary bed.A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis.Aerobic exercise training does not alter vascular structure and function in chronic obstructive pulmonary disease.Obesity and metabolic syndrome in COPD: is exercise the answer?Does pulmonary rehabilitation reduce peripheral blood pressure in patients with chronic obstructive pulmonary disease?Central Fat and Peripheral Muscle

P2860

Q26740768-A3BB265A-780D-4DFB-87B8-6BD29F0C58CA Q26799659-76FFA5A2-4518-4E35-83BB-313E4D8CE640 Q30251588-6956807B-2C27-417F-8C55-015F9BE8B7BD Q35081435-DA1CEAB6-2307-468A-B400-9F00B64C5253 Q36068392-225C8A95-4907-4BA9-BC4F-D920674D27D0 Q36539136-8D760628-3D20-4DE3-820F-A3296B396BEB Q36567428-857A620E-9EDE-4CB1-A911-58D9CAAB9E71 Q37288641-B1A1A7C2-5968-428B-A61B-E1969F341ECC Q37603596-0789D166-27A1-4D91-A211-41BD77C94F6F Q37940008-34DB6EA1-12C6-4027-B3C9-1BAD0CF4E7CC Q38580083-039FE85C-C950-47C2-854D-F5A307A583A2 Q38635174-C9682AF6-C6D9-454A-A636-6617F3840AB5 Q47850975-34E26C09-B586-4092-BDA0-02229B43AA5E Q51627923-E2362117-8C36-4E69-94D4-6BBA2DFC55C5 Q56507512-66CFADB9-B551-4FCF-A3CD-4C2385FE93B6

P2860

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

http://www.wikidata.org/entity/Q33878940

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

@ast

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

@en

type

label

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

@ast

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

@en

prefLabel

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

@ast

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

@en

P1433

Q33878940-85AC1D74-86A5-41DF-AA0B-AD13B8BE1822

P1476

Q33878940-39A54C5F-A492-48BE-8BED-1669F6AD7265

P2093

Q33878940-1E421229-CA68-4119-9DB8-271930014FD6

Q33878940-29B7EB32-1129-4085-A1FA-326257884E3A

Q33878940-90DD6BF7-2FC2-4F23-815D-75A14287B394

Q33878940-D4A7B2CA-4F54-4D05-8373-D5C6E6A91B33

Q33878940-FE83944D-F581-42DD-83BC-F7AADD7EA7D9

P2860

Q33878940-08F67DFE-FA06-4A7D-82DA-2BADEE866D39

Q33878940-0D38530A-9951-4699-B3B1-6E0780D2C8E5

Q33878940-138A8A80-B936-4DCB-85B7-5F1F6C0A87FD

Q33878940-1BAC0961-64C1-4EE3-9054-F2F7EBF67EDF

Q33878940-1C220292-FDA6-482D-928C-A960E68CE356

Q33878940-3A9FF2E2-9239-470B-B6C6-F422DFD642D2

Q33878940-3FF67513-D184-4936-AFE8-A91CF0540F23

Q33878940-51FA24AD-D057-498D-826D-0B7BDBA04ECA

Q33878940-5214F1B9-76C0-4297-BFD5-DFD20DDBF51E

Q33878940-5A4C4935-C704-4876-B95E-B2C23CDB0A82

P2888

Q33878940-52E35F3F-642F-413B-BCD7-16778DE7B8A8

P304

Q33878940-1FB63F7D-CBA7-4F99-8836-D877E4E9BFF2

P31

Q33878940-3DF519CD-90C6-4609-9A6C-CDF078605EA9

P356

Q33878940-1AB23087-C576-4018-87BD-2B44DB274E39

P478

Q33878940-9EE60619-C6EB-4ACA-A458-9439FE4588DF

P50

Q33878940-20797FF0-281C-4477-AFED-8BD4882896FF

P577

Q33878940-2137AD34-6781-4466-A4ED-07835F16855D

P5875

Q33878940-7B84FAB5-C951-4CB2-9018-D60C95FD4303

P6179

Q33878940-BD62D3F6-3658-42BB-827E-B6E8E60D93B0

P698

Q33878940-B19F0F76-FF4C-4C05-B447-2C09881AD6C6

P921

Q33878940-A8301E14-A324-43C7-B450-E8B29F3CD820

P932

Q33878940-BE742B6F-BE86-4C15-BDA2-5F312996CBFA

P356

1471-2466-11-20

P1433

BMC Pulmonary Medicine

P1476

Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD?

@en

P2093

Dennis J Shale

http://www.w3.org/2001/XMLSchema#string

James M Duckers

http://www.w3.org/2001/XMLSchema#string

John R Cockcroft

http://www.w3.org/2001/XMLSchema#string

Nichola S Gale

http://www.w3.org/2001/XMLSchema#string

Stephanie Enright

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Standardisation of spirometry

Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.

Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials.

Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Interpreting thresholds for a clinically significant change in health status in asthma and COPD.

Exercise and hypertension: facts and uncertainties.

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.

Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee

P2888

1471-2466-11-20

P304

20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2466-11-20

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Charlotte E Bolton

P577

2011-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51068188

http://www.w3.org/2001/XMLSchema#string

P6179

1016424956

http://www.w3.org/2001/XMLSchema#string

P698

21510856

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3110113

http://www.w3.org/2001/XMLSchema#string